| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8658090 | Chest | 2018 | 62 Pages | 
Abstract
												Subgroups of smokers defined by upper-lobe or lower-lobe emphysema predominance exhibit different functional and radiological disease progression rates, and the upper-lobe predominant subtype shows evidence of association with known COPD genetic risk variants. These subgroups may be useful in the development of personalized treatments for COPD.
											Keywords
												
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Cardiology and Cardiovascular Medicine
												
											Authors
												Adel MD, Yale PhD, Michael H. MD, MPH, George R. MD, Raul PhD, Russell P. MD, James D. MD, Dawn L. MD, MPH, Jennifer G. PhD, Edwin K. MD, PhD, Peter J. MD, 
											